Background: Imaging evaluation of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging. Myocardial strain assessment by echocardiography is an increasingly utilized technique for detecting subclinical left ventricular (LV) and right ventricular (RV) dysfunction. We aimed to evaluate the diagnostic and prognostic utility of LV and RV strain in ARVC.
Methods: Patients with suspected ARVC (n = 109) from a multicenter registry were clinically phenotyped using the 2010 ARVC Revised Task Force Criteria and underwent baseline strain echocardiography. Diagnostic performance of LV and RV strain was evaluated using the area under the receiver operating characteristic curve analysis against the 2010 ARVC Revised Task Force Criteria, and the prognostic value was assessed using the Kaplan-Meier analysis.
Results: Mean age was 45.3±14.7 years, and 48% of patients were female. Estimation of RV strain was feasible in 99/109 (91%), and LV strain was feasible in 85/109 (78%) patients. ARVC prevalence by 2010 ARVC Revised Task Force Criteria is 91/109 (83%) and 83/99 (84%) in those with RV strain measurements. RV global longitudinal strain and RV free wall strain had diagnostic area under the receiver operating characteristic curve of 0.76 and 0.77, respectively (both <0.001; difference NS). Abnormal RV global longitudinal strain phenotype (RV global longitudinal strain > -17.9%) and RV free wall strain phenotype (RV free wall strain > -21.2%) were identified in 41/69 (59%) and 56/69 (81%) of subjects, respectively, who were not identified by conventional echocardiographic criteria but still met the overall 2010 ARVC Revised Task Force Criteria for ARVC. LV global longitudinal strain did not add diagnostic value but was prognostic for composite end points of death, heart transplantation, or ventricular arrhythmia (log-rank =0.04).
Conclusions: In a prospective, multicenter registry of ARVC, RV strain assessment added diagnostic value to current echocardiographic criteria by identifying patients who are missed by current echocardiographic criteria yet still fulfill the diagnosis of ARVC. LV strain, by contrast, did not add incremental diagnostic value but was prognostic for identification of high-risk patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803132 | PMC |
| http://dx.doi.org/10.1161/CIRCIMAGING.123.015671 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incremental Prognostic Value of Cardiac MRI Feature Tracking and T1 Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy.
Radiol Cardiothorac Imaging
October 2024
From the Department of Radiology (G.L., L.C., W.Y., X.L., J.O., Y.Y., H.L.) and Guangdong Cardiovascular Institute (Q.Z., Y.L.), Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106 Zhongshan 2nd Road, Guangzhou 510080, China; Department of Interventional Diagnosis and Therapy, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (G.L.); Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China (X.W.); Department of Radiology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China (J.X.); Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China (Z.D.); Department of Pediatrics, The First Clinical College, Guangdong Medical University, Zhanjiang, China (X.Z.); and School of Medicine, South China University of Technology, Guangzhou, China (X.L., H.L.).
Purpose To explore the role of cardiac MRI feature tracking (FT) and T1 mapping in predicting sustained ventricular arrhythmias (VA) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and to investigate their possible incremental value beyond ARVC risk score. Materials and Methods The retrospective study analyzed 91 patients with ARVC (median age, 36 years [IQR, 27-50 years]; 60 male, 31 female) who underwent cardiac MRI examinations between November 2010 and March 2022. The primary end point was the first occurrence of sustained VA after cardiac MRI to first VA, with censoring of patients who were alive without VA at last follow-up.
View Article and Find Full Text PDFA right ventricular bulge: A clinical dilemma in diagnosis.
J Clin Ultrasound
September 2024
Cardiology Department, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Article Synopsis
- - Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition that leads to replacement of heart muscle with fibrofatty tissue, which can cause serious cardiac issues, especially in young athletes.
- - Individuals often present asymptomatically but may experience sudden cardiac problems, including fainting or sudden cardiac death, making it a critical condition to identify.
- - Diagnosing ARVC is challenging due to its varying symptoms and lack of clear diagnostic criteria, with a focus on assessing right ventricular wall motion through echocardiography as outlined in the 2010 revised task force criteria.
Correlation between Epsilon Wave and Late Potentials in Arrhythmogenic Right Ventricular Cardiomyopathy-Do Late Potentials Define the Epsilon Wave?
J Clin Med
August 2024
Cardinal Wyszynski National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
Article Synopsis
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic condition leading to heart muscle deterioration, mainly in the right ventricle, which can cause serious heart problems and arrhythmias, making diagnosis complex due to varying symptoms.
- The study aimed to investigate the connection between the epsilon wave (EW) seen on ECG and late ventricular potentials (LPs) in ARVC patients, and how these relate to right ventricular (RV) changes.
- The findings revealed that EW was significantly more frequent in ARVC patients with positive LPs, indicating a strong link between the presence of these signals and physical changes in the heart, with specific measurements of RV size and function further correlating with LPs presence.
Improved diagnosis of arrhythmogenic right ventricular cardiomyopathy using electrocardiographic deep learning.
Heart Rhythm
August 2024
Heart and Vascular Institute, Johns Hopkins Hospital, Baltimore, Maryland.
Article Synopsis
- ARVC is a rare genetic heart condition that can lead to dangerous heart rhythms, and its diagnosis often relies on expert evaluation using specific criteria.* -
- This study aimed to create and validate a deep learning tool that analyzes ECGs to diagnose ARVC, using data from 688 patients, with mixed results from cardiologists but strong performance from the ECG-DL model.* -
- The ECG-DL tool demonstrated excellent accuracy in identifying ARVC cases, matching the diagnostic level of seasoned experts, and showed improved results when combined with traditional diagnostic criteria.*
Diagnostic value of late gadolinium enhancement at cardiovascular magnetic resonance to distinguish arrhythmogenic right ventricular cardiomyopathy from differentials.
J Cardiovasc Magn Reson
December 2024
Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands. Electronic address:
Background: While late gadolinium enhancement (LGE) is proposed as a diagnostic criterion for arrhythmogenic right ventricular cardiomyopathy (ARVC), the potential of LGE to distinguish ARVC from differentials remains unknown. We aimed to assess the diagnostic value of LGE for ARVC diagnosis.
Methods: We included 132 subjects (60% male, 47 ± 11 years) who had undergone cardiac magnetic resonance imaging with LGE assessment for ARVC or ARVC differentials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!